PBYI
PBYI
NASDAQ · Biotechnology

Puma Biotechnology Inc

$6.19
-0.06 (-0.96%)
As of Mar 24, 3:26 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target -12.0% upside
Low Target $2.99
Average Target $5.45
High Target $6.80
Current Price $6.19
Current
$6.19
Target
$5.45
$2.99 $5.45 avg $6.80
Scenario Analysis
Bear Case
$2.99
-51.7%
Low target
Base Case
$5.45
-12.0%
Avg target
Bull Case
$6.80
+9.9%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$7.68
-19.4% from high
52-Week Low
$2.58
+140.4% from low
Target vs 52W High
$5.45
-29.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%